Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uremic bleeding: pathogenesis and therapy

A L Weigert1, A I Schafer

  • 1Hospital de Santa Cruz and Faculdade de Medicina de Universidade Classica de Lisboa, Lisbon, Portugal.

The American Journal of the Medical Sciences
|August 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Candida species contamination of preservation fluid-outcome of renal transplantation in 6 patients.

Transplantation proceedings·2013
Same author

The effect of intermittent operation on a wind-powered membrane system for brackish water desalination.

Water science and technology : a journal of the International Association on Water Pollution Research·2012
Same author

Endothelium-derived Relaxing Factor Inhibits Shear Stress-induced Platelet Aggregation.

Platelets·2010
Same author

Streptokinase inhibits acute platelet thrombus formation in stenosed dog coronary arteries.

Platelets·2010
Same author

Renewable energy powered membrane technology. 2. The effect of energy fluctuations on performance of a photovoltaic hybrid membrane system.

Environmental science & technology·2008

Uremic bleeding is complex, but bleeding time is a key indicator. Dialysis and erythropoietin are improving management of this bleeding risk in kidney disease patients.

Area of Science:

  • Nephrology
  • Hematology
  • Internal Medicine

Background:

  • Uremic bleeding diathesis presents significant clinical challenges.
  • Understanding its pathophysiology is crucial for effective patient management.

Purpose of the Study:

  • To review the pathophysiology of uremic bleeding.
  • To discuss current therapeutic interventions for bleeding risk in uremic patients.

Main Methods:

  • Comprehensive literature search of existing research and reviews.
  • Analysis of studies on uremic bleeding pathophysiology and clinical management.

Main Results:

  • Common bleeding includes prolonged oozing, epistaxis, GI/GU bleeding, and subdural hematomas.
  • Bleeding time is the most reliable test for assessing bleeding risk and treatment response.

Related Experiment Videos

  • Anemia, assessed by hematocrit, significantly impacts bleeding risk; correction via transfusions or erythropoietin is vital.
  • Dialysis improves hemostasis; renal transplantation resolves it.
  • Desmopressin acetate and conjugated estrogens are key therapeutic agents, each with distinct onset and duration profiles.

    • Conclusions:

    • The pathophysiology of uremic bleeding is complex and not fully elucidated.
    • Empirically developed clinical tests and therapies have proven useful.
    • Widespread dialysis and erythropoietin are expected to decrease the incidence and severity of uremic bleeding.